the need to identify diabetes and other forms of glucose abnormalities in asymptomatic subjects.
Elevated plasma glucose levels on admission (APG) are common in patients admitted with acute coronary syndromes (ACS) and are associated with a high incidence of adverse clinical outcomes, particularly compared with patients with normoglycaemic ACS. [5] [6] [7] [8] Nevertheless, hyperglycaemia remains unrecognized and untreated in a considerable portion of patients with ACS. 9 Clinicians may consider an elevated APG as a parameter of the temporary physical stress that is a natural part of and caused by the ACS which will normalize once the coronary event is adequately managed. It should be realized, however, that elevated APG can also be a sign of hitherto unrecognized diabetes mellitus. In this respect, the lack of knowledge of an elevated APG is of concern as the prevalence of undiagnosed diabetes will be underestimated. 10 The European Society of Cardiology and the European Association for the Study of Diabetes (EASD) already advocate investigating glucose metabolism in patients without known diabetes but with established cardiovascular disease through an oral glucose tolerance test (OGTT). 11 However, a recent survey in the Netherlands showed that 76% of cardiologists do not routinely measure HbA1c prior to discharge in patients with ACS. 9 With this in mind, it is unlikely that the more labour-intensive OGTT is standard care in daily cardiology practice. 6 A substantial number of ACS patients get admitted in the Cardiology Department of Dhaka Medical College Hospital with admission hypergylcaemia. The aim of the study is to compare different diagnostic methods for detecting undiagnosed diabetes mellitus in ACS patients with admission hyperglycaemia .
Methods:
It was a cross sectional comparative study carried out in the department of Cardiology, Dhaka Medical College Hospital (DMCH), Dhaka during the period of May, 2012 to April, 2013. All the patients of Acute Coronary Syndrome (ACS) with admission plasma glucose (APG) e"7.8 mmol/L, admitted in the coronary care unit, DMCH, Dhaka within the study period were taken as sampling population. Patients with structural heart disease (i.e. congenital heart disease, valvular heart disease, cardiomyopathy etc), patients with previously diagnosed case of Diabetes mellitus (with or without taking ant-diabetic drugs), patients with ongoing treatment with glucocorticoids or immunosuppressive agents, patients with serious co-morbid conditions (i.e. CKD, CLD, Malignancy) and unwilling to participate were excluded from the study. Sampling technique was purposive and sample size was 157. Informed consent was taken from each patient or from legal guardian. Initial evaluation of patients was performed by history and clinical examination. The diagnosis of acute coronary syndrome (ACS) was done by identifying the triad of clinical presentation (including a history of coronary artery disease), electrocardiographic changes and biochemical cardiac markers. Then APG level was tested for each patient. Baseline investigation e.g., serum creatinine, fasting lipid profile, echocardiography was done for each patients. Subsequent blood sample was taken for HbA1c. Pre-discharge OGTT was performed according to a standardized protocol with 75 gm glucose. Five ml venous blood was drawn by sterile disposable plastic syringe with aseptic precaution from ante-cubital vein of the subjects by a specified person. Collected blood was kept in test tubes without any anti-coagulant and labeled. Then specimens were sent to the department of Biochemistry/Clinical pathology, Dhaka Medical College Hospital. APG, fasting plasma glucose (FPG), OGTT were done by enzymatic method by AE-30F machine (made by China). HbA1c were done by enzymatic method by Nycocard reader II (made by China). APG, FPG, HbA1c was compared with pre-discharge OGTT for detecting undiagnosed diabetes in ACS patients with admission hyperglycaemia. All the information was properly noted in the preformed data collection sheet. Data was analyzed by using SPSS (statistical package for the social science) version 16.0. Continuous data were expressed as mean ± standard deviation of mean and categorical data as percentages . Test statistics to be used to analyze the data are descriptive statistics, Chi square test, and analysis of variance. Level of significance was set at 0.05.
Results:
The study enrolled 157 patients of ACS with admission hyperglycaemia but without known diabetes mellitus. The objective of the study was to compare the performance of APG level, FPG level and HbA1c to diagnose diabetes mellitus considering pre-discharge OGTT levels as a gold standard. The findings of the study are in tables. Distribution of traditional risk factors revealed that the prevalence of dyslipidaemia was quite high (70.7%), it was more in diabetic patients (84.2%) than in non-diabetic patients (63%). Smoking was also more prevalent in diabetic group than in nondiabetic group (73.6% vs 67%) & total prevalence was 69.42%. Prevalence of hypertension was present in 61.8% in study subjects, 58.0% in nondiabetic and 68.4% in diabetic group. Table- IV shows according to admission plasma glucose level 29 (18.5%) patients were diabetic with admission plasma glucose level e"11.1 mmol/l and 128 (81.3%) patients were non-diabetic with admission plasma glucose level <11.1 mmol/l ( Table-IV) . 
Discussion:
Detecting abnormal glucose metabolism For decades, the diagnosis of diabetes was based on plasma glucose criteria, either the fasting plasma glucose (FPG) or the 2-h value in the 75-g OGTT. In 2009, an International Expert Committee that included representatives of the ADA, the International Diabetes Federation (IDF), and the EASD recommended the use of the HbA1C test to diagnose diabetes, with a threshold of e"6.5%, and the ADA adopted this criterion in 2010.
Which of these is most appropriate for detecting undiagnosed diabetes in the setting of ACS remains to be clearly defined? The HbA1c has several advantages to the FPG and OGTT, including greater convenience (since fasting is not required), evidence to suggest greater pre analytical stability, and less day-to-day perturbations during periods of stress and illness. These advantages must be balanced by greater cost, the limited availability of HbA1c testing in certain regions of the developing world, and the incomplete correlation between HbA1c and average glucose in certain individuals. 12 Diabetes Mellitus and Coronary Heart Disease Diabetes mellitus has an important impact on vascular disease. About three-quarters of diabetic patients die from cardiovascular disease and twothirds of these die from the manifestations of ischemic heart disease, promoting coronary artery disease to be the leading cause of morbidity and mortality in patients with diabetes mellitus. 13 Patients with diabetes are more likely to experience acute myocardial infarction (AMI) and heart failure, and are at a greater risk of dying from an acute cardiac event than patients without diabetes. These differences may be related to the severity and extent of coronary heart disease in diabetic patients, the extent of left ventricular remodeling, and the presence of significant ventricular arrhythmias. However, the main reason for increased pre hospital, hospital and 1-
Fig 1: Receiver operating characteristic (ROC) curves comparing different diagnostic methods for diabetes.
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year post-hospital mortality in diabetic patients is the development of heart failure after AMI. Sudden death and fatal ventricular arrhythmias contribute to a lesser extent to the increased mortality rate. 13 Nondiabetic Glucose Disturbances and Acute Coronary Syndromes Hyperglycemia may also occur in patients without prior history of diabetes. In some, it is transient and may normalize in the following days (therefore called 'stress hyperglycemia'), but in others it is persistent reflecting the presence of diabetes mellitus. Stress hyperglycemia is not an event exclusively specific for ACS. In almost all states of acute illness, blood glucose levels may be elevated. Despite the fact that stress hyperglycemia is a common event, but it still lacks a widely accepted definition. Most authors consider hospital admission plasma glucose as a relevant finding, but the threshold value for stress induced elevated plasma glucose is still under dispute. However, most authors simply use definitions of non-stress hyperglycemia, according to ADA or WHO guideline. 13 Stress hyperglycemia during critical illness has long been considered essential to provide fuel for vital organs and hence was interpreted as a beneficial adaptation. Evidence is now growing against this notion as hyperglycemia is identified as an independent risk factor for adverse outcome of numerous surgical and medical conditions, and avoiding hyperglycemia with intensive therapy has been shown to improve the outcome. 13 Some prospective studies have reported on abnormal glucose metabolism in patients with cardiovascular disease. The Glucose tolerance in patients with Acute Myocardial Infarction (GAMI) study was designed to detect the prevalence of dysglycaemia in patients admitted to hospital with AMI. An OGTT was performed at hospital discharge, about four to five days after the MI (n=164), and again three months later (n=144). Abnormal glucose metabolism was detected in approximately two thirds of patients at hospital discharge -35% had prediabetes and 31% newly diagnosed T2DM. A similar prevalence was recorded three months later, suggesting that increased sympathetic drive induced by the acute illness was not the main reason for the metabolic imbalance, and that testing before discharge from hospital provided an accurate reflection of the glucometabolic status. 14 The present study showed that despite having admission hyperglycaemia only 36. 
